top of page



Polyplus is a leading upstream solutions provider for advanced biologic  and cell and gene therapy production from research to commercial scale.  An innovator in nucleic acid delivery, the legacy portfolio features  process-centric transfection reagents, kits, and support services.  Custom plasmid vector design was integrated into the offer in 2022 as a  first measure to expanding the products and services portfolio to help  customers (or the industry) optimize process economics while meeting  strict scientific and regulatory standards. Headquartered in Europe, the  Polyplus team continues to grow globally with operations in the United  States and Asia. 

Learn more at Polyplus® | Expertise - Quality - Support (

bottom of page